Bruno Marc A sold $4.3M of ARMK

Bruno Marc A (COO, U.S. Food & Facilities) sold 70,634 shares of Aramark (ARMK) at an average of $61.03 ($60.92–$61.42, $4.31M total) across 2 trades on 2026-08-13.

Original reporting
SEC EDGAR · Bruno Marc A
Published Aug 14, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARMK
Neutral
medium confidence
Mentioned
$ARMK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARMKNeutralLow
01

Why it matters

The only new fact is the insider’s open-market sale size, timing (2026-08-13), and price range, with holdings after the transaction. No company guidance, earnings, or operational update is included.

02

Market read

Traders may monitor ARMK for sentiment effects from insider selling, but the disclosure lacks fundamental catalysts.

03

What to watch

Insider sales often have non-informational drivers (taxes, diversification, pre-scheduled personal needs). The filing does not provide intent or any link to company performance.

Relevance 6/10Novelty 4/10Timing: SEC Form 4 filed after-hours on 2026-08-14, reflecting insider sale disclosed today.

Background

The article is an SEC Form 4 insider transaction disclosure for Aramark (ARMK) by its COO, U.S. Food & Facilities, Bruno Marc A.

Company-level read

Ticker impact

$ARMKNeutralMedium confidence
Context

Aramark COO Bruno Marc A sold about 70,634 shares in open-market transactions totaling $4.31M, per a fresh SEC Form 4 filed today.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment and should be weighed against typical 10b5-1 vs non-10b5-1 context.

Evidence & confidence

The filing is a primary-source insider transaction with a stated sale price range and no 10b5-1 plan, but it does not include new operational, financial, or guidance information.

Market effects

Minimal; insider sales at a single food services/facilities company do not materially reset sector expectations.

None indicated.

None indicated.

Counterpoint

Because the sale is not tied to a 10b5-1 plan, some traders may over-interpret it as negative; the transaction could still be routine liquidity planning.

Key entities

  • Aramark

    Subject of the Form 4 insider sale disclosure.

  • Bruno Marc A

    COO, U.S. Food & Facilities, reported open-market sale of ARMK shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ARMKMed

Aramark Q4 2026 Earnings Call Summary

Aramark reported record annualized gross new client wins of $1.9 billion, a 97% client retention rate, and launched Aramark Nexus. The company reduced its leverage ratio to 2.7x, enabling a $1 billion share repurchase program and a 17% dividend increase. For fiscal 2027, Aramark projects $500 million in revenue from Nexus, 9-10% organic revenue growth, and 15-19% adjusted operating income growth. Management highlighted supply chain efficiencies and mitigating inflation impacts.

$ARMKMed

Aramark (ARMK) Q4 2026 Earnings Call Transcript

Aramark (ARMK) reported Q4 2026 revenue of $20.1B, up 10% YoY, with U.S. and international organic growth of 8% and 12%, respectively. Adjusted EPS grew 21% on a constant currency basis. The company announced a $1B share repurchase program and a 17% dividend increase. Key segments like Collegiate Hospitality and Healthcare Plus drove growth. Aramark Nexus contributed 1% to organic revenue growth, scaling premium hospitality services.

$ARMKHigh

Why is Aramark stock sliding today?

Aramark (ARMK) shares fell 4.7% pre-market after reporting Q4 2026 results that missed estimates, with adjusted EPS at $0.71 vs. $0.75 and revenue at $5.29B vs. $5.30B. The company's fiscal 2027 guidance also fell short of expectations. Despite a 25% YoY EPS increase and 4.8% revenue growth, the stock dropped due to broader market pressures and the earnings miss.